BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Algeta AS 

Kjelsasveien 172 A
P.O. Box 54 Kjelsas
Oslo    NO-0411  Norway
Phone: 47-23-00-79-90 Fax: 47-23-00-79-91


SEARCH JOBS


Industry
Pharmaceutical

Segment
Pharmaceuticals





 Company News
Bayer AG (BAYN.DE) Clinches $2.9 Billion Deal For Norway's Algeta 2/24/2014 7:14:33 AM    More...
Algeta Release: Net Sales of Xofigo (radium Ra 223 dichloride) Injection for Third Quarter 2013 10/31/2013 12:54:27 PM    More...
Algeta Release: New Data and Analyses From the Phase 3 ALSYMPCA Trial of Xofigo® (Radium Ra 223 Dichloride) Injection to be Presented at the European Cancer Congress (ECCO-ESMO-ESTRO) 2013 9/12/2013 9:36:33 AM    More...
Algeta Schedules First Half and Second Quarter 2013 Results Presentation, Webcast and Conference Call 8/19/2013 9:22:03 AM    More...
Algeta Appoints Dr Andreas Menrad as Chief Scientific Officer 8/19/2013 9:20:45 AM    More...
Algeta Celebrates the Official Opening of Its Commercial Production Facility for Xofigo® (Radium Ra 223 Dichloride) Injection at the Institute for Energy Technology (IFE) in Norway 6/21/2013 10:22:35 AM    More...
Algeta: New Data and Analyses From Clinical Trials of Xofigo(R) (Radium Ra 223 Dichloride) to be Presented at American Society of Clinical Oncology 5/17/2013 10:34:30 AM    More...
Algeta Results for the First Quarter 2013 5/15/2013 10:58:15 AM    More...
Bayer AG (BAY.F), Algeta Win FDA Approval for Prostate Cancer Drug 5/15/2013 10:05:10 AM    More...
Algeta Schedules First Quarter 2013 Results Presentation, Webcast and Conference Call 5/7/2013 10:20:30 AM    More...
1234

//-->